Log in to save to my catalogue

Subtyping non-small cell lung cancer by histology-guided spatial metabolomics

Subtyping non-small cell lung cancer by histology-guided spatial metabolomics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8800912

Subtyping non-small cell lung cancer by histology-guided spatial metabolomics

About this item

Full title

Subtyping non-small cell lung cancer by histology-guided spatial metabolomics

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of cancer research and clinical oncology, 2022-02, Vol.148 (2), p.351-360

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Most cancer-related deaths worldwide are associated with lung cancer. Subtyping of non-small cell lung cancer (NSCLC) into adenocarcinoma (AC) and squamous cell carcinoma (SqCC) is of importance, as therapy regimes differ. However, conventional staining and immunohistochemistry have their limitations. Therefore, a spatial metabolomics ap...

Alternative Titles

Full title

Subtyping non-small cell lung cancer by histology-guided spatial metabolomics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8800912

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8800912

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s00432-021-03834-w

How to access this item